Functional variants in NOS3 and other genes of the NOS‐NO pathway have been associated with hypertension.6 Hence, we explored the possibility that the effects of genetically determined dysregulation of the nitric oxide synthase–nitric oxide (NOS‐NO) pathway on stroke risk are mediated via BP using a 2‐sample MR analysis. This evidence concerns the gene NOS3 and hypertensive disorder.